How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/c1-inhibitor-human.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-14 · How we verify

C1 Inhibitor Human — Competitive Intelligence Brief

C1 Inhibitor Human (C1 Inhibitor Human) competitive landscape: 1 comparator, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Plasma-derived protease inhibitor. Area: Immunology / Rare Genetic Disorders.

marketed Plasma-derived protease inhibitor C1 esterase inhibitor (C1-INH) Immunology / Rare Genetic Disorders Small molecule Live · refreshed every 30 min

Target snapshot

C1 Inhibitor Human (C1 Inhibitor Human) — GCS Ramsay Santé pour l'Enseignement et la Recherche. C1 Inhibitor Human is a plasma-derived protein replacement therapy that restores deficient or dysfunctional C1 esterase inhibitor to prevent excessive bradykinin generation and control hereditary angioedema attacks.

Comparator set (1 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
C1 Inhibitor Human TARGET	C1 Inhibitor Human	GCS Ramsay Santé pour l'Enseignement et la Recherche	marketed	Plasma-derived protease inhibitor	C1 esterase inhibitor (C1-INH)
Antithrombin III	Antithrombin III	Octapharma	marketed	Anticoagulant; plasma-derived protease inhibitor	Thrombin (Factor IIa); Factor Xa

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Plasma-derived protease inhibitor class)

GCS Ramsay Santé pour l'Enseignement et la Recherche · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). C1 Inhibitor Human — Competitive Intelligence Brief. https://druglandscape.com/ci/c1-inhibitor-human. Accessed 2026-05-14.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab